The clinical performance is complex and often involves multiple systems. Early identification and normalisation of the diagnosis is essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological checkups.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment for the treatment and management of prognosis of the disease requires individualized development, typically including drug therapy, rehabilitation, regular follow-up, and multi-dimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of adult types of low-phosphate kinase. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.